N-(2-{3-[3,5-Bis(Tifluoromethyl)Phenyl]Ureido}Ethyl)-Glycyrrhetin-amide: A novel anticancer glycyrrhetinic acid derivative that targets the proteasome.

Authors
Publication date
1 January 2011
Publisher

Abstract

info:eu-repo/semantics/nonPublishe

    Similar works

    Full text

    thumbnail-image

    Available Versions

    DI-fusion

    redirect
    oaioai:dipot.ulb.ac.be:2013/13508...
    Last time updated on 09/01/2013